Company / Revenue
Corbus Pharmaceuticals Holdings, Inc. Revenue History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$881.7K
FY2022
5-year range
$881.7K / $36.1M
FY2018-FY2022
Trend
-77.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $36M to $881,705 over the past 2 years.
Based on SEC 10-K filings.
$881,705 in FY2022 with a 5-year CAGR of +6.3%.
Declined from $36M to $881,705 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -43.2%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +6.3%, indicating consistent growth.
- In FY2022, revenue decreased 77.6% year-over-year.
- Peak revenue was recorded in FY2020.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $881.7K | -77.6% |
| FY2021 | $3.9M | -89.1% |
| FY2020 | $36.1M | +649.5% |
| FY2019 | $4.8M | +97.6% |
| FY2018 | $2.4M | +276.4% |
| FY2017 | $648.4K | +0.0% |
| FY2016 | $648.4K | +0.0% |
| FY2015 | $648.4K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026